Amelie Dos Santos

Poitiers, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Journal: Neurology

Published: May 05, 2026

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

Journal: CNS drugs

Published: September 04, 2025

Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.

Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.

Journal: JAMA neurology

Published: August 04, 2025

Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

Journal: Neurology

Published: July 30, 2025

Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis.

Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis.

Journal: Brain : a journal of neurology

Published: July 21, 2025

Bilateral myelin oligodendrocyte glycoprotein antibody-associated disease after cataract surgery.

Bilateral myelin oligodendrocyte glycoprotein antibody-associated disease after cataract surgery.

Journal: American journal of ophthalmology case reports

Published: July 18, 2025

Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Journal: Neurology

Published: July 16, 2025

Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis.

Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: May 16, 2025

Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French population.

Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French population.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 18, 2025

Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis.

Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 11, 2025

Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: A 6-year follow-up.

Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: A 6-year follow-up.

Journal: Multiple sclerosis and related disorders

Published: August 26, 2023

Neurosarcoidosis: Clinical, biological, and MRI presentation of central nervous system disease in a national multicenter cohort.

Neurosarcoidosis: Clinical, biological, and MRI presentation of central nervous system disease in a national multicenter cohort.

Journal: Brain and behavior

Published: April 14, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026